News

IATA data points to a fourth consecutive month of double-digit, year-on-year growth.

The merger exponentially grows ONO’s oncology pipeline.

The complex will research solutions for manufacturing antibodies, mRNA applications, and more.

A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.

The CDMO’s boost in production will be centered around pharmaceutical products.

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

The move features the launch of an innovation center revolving around cell and gene services.

The latest news for pharma industry insiders.

The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.

Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.

Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, discusses the process of keeping the event relevant to the times.

Approval comes amid positive results of a single-arm trial, showing a complete response rate of 77% in patients with Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.

The latest news for pharma industry insiders.

Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters.

The rationale behind transforming case management in healthcare.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

The latest news for pharma industry insiders.

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

The latest news for pharma industry insiders.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Data from the Phase III APPLAUSE-IgAN study showed a 38.3% reduction in proteinuria in patients treated with Fabhalta for IgA nephropathy compared to placebo.